Humacyte HUMA Q4 2025 Annual earnings
Reported March 27, 2026 · Before market open
Revenue$467.0KMiss by $882.3K
EPS-$0.13In line
Revenue estimate$1.3M
EPS estimate-$0.13
Next report
Aug 10, 2026 (In 1 week)Revenue estimate$1.1M
EPS estimate-$0.10
Versus estimates
Revenue
Ask the moment Humacyte reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Humacyte report Q4 2025 earnings?
- Humacyte (HUMA) reported Q4 2025 earnings on March 27, 2026 before market open.
- What were Humacyte's Q4 2025 revenue and EPS?
- Humacyte reported revenue of $467.0K and eps of $-0.13 for Q4 2025.
- Did Humacyte beat estimates in Q4 2025?
- Revenue missed the consensus estimate of $1.3M by $882.3K. EPS beat the consensus estimate of $-0.13 by $0.00.
- How did Humacyte's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 93.5% from $7.2M a year earlier and eps grew 18.8% from $-0.16.
- Where can I find Humacyte's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001818382-26-000004) directly on SEC EDGAR. The filing index links above go to sec.gov.